1xbet 다운로드., Ltd.

First Time 1xbet 다운로드 the World That a Drug Has Been Granted an 1xbet 다운로드dication For This Medical Condition

• Aquaretic agent Samsca was approved 1xbet 다운로드 for the treatment of volume overload in patients with liver cirrhosis. Approval of this new indication 1xbet 다운로드 is the first such approval in the world, offering a new treatment option to hepatic cirrhosis patients experiencing difficulties or inadequacy with conventional diuretic treatments.
• One-third of the estimated two hundred and seventy thousand hepatic cirrhosis patients 1xbet 다운로드 are said to be facing difficulties in daily living, with swollen hands and legs, and abdominal bloating (ascites). Diuretics are usually prescribed to treat such conditions, but as they cause some patients to experience electrolytic imbalances and declines in kidney function, a new treatment with a different mechanism of action was long desired.
• Certa1xbet 다운로드 precautions are required when us1xbet 다운로드g Samsca, such as 1xbet 다운로드itiation or re-1xbet 다운로드itiation only under hospitalization. Patients tak1xbet 다운로드g Samsca must have their serum sodium concentration and liver function monitored, both on a frequent basis. The maximum approved dosage of Samsca is 7.5mg for the treatment of fluid retention 1xbet 다운로드 hepatic cirrhosis patients, which is half the dose approved for the treatment of volume overload 1xbet 다운로드 patients with heart failure.

1xbet 다운로드., Ltd. (head office: Tokyo, Japan; president and representative director: Taro Iwamoto) obtained regulatory approval on September 13, from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Samsca^®7.5mg Tablets (tolvaptan) as treatment for fluid retention 1xbet 다운로드 hepatic cirrhosis patients.